BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1725661)

  • 21. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of automated plasmapheresis on clinical, haematological, biochemical and coagulation variables in horses.
    Feige K; Ehrat FB; Kästner SB; Wampfler B
    Vet J; 2005 Jan; 169(1):102-7. PubMed ID: 15683770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis for the preparation of HIV free cryoprecipitate.
    Tardtong P; Chuansumrit A; Stabanswadigan S; Chiewsilp P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():195-7. PubMed ID: 7886572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of plasmapheresis on the blood donors. Changes caused by long-term plasmapheresis in normal donors].
    Pistotnik M; Grgicević D; Flego DG
    Bilt Hematol Transfuz; 1975; 3(1-2):31-6. PubMed ID: 1225316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated automated plasmapheresis in goats (Capra hircus): a clinically safe and long-term refinement to current antibody recovery techniques.
    Klages C
    J Am Assoc Lab Anim Sci; 2006 Nov; 45(6):49-53. PubMed ID: 17089992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Starting a plasmapheresis program with hollow-fiber filtration.
    van der Does JA; van Antwerpen CE
    Vox Sang; 1986; 51 Suppl 1():45-8. PubMed ID: 3090785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study for large-scale plasma procurement using automated plasmapheresis.
    Robinson AE; Penny AF; Smith J; Tovey DL
    Vox Sang; 1983 Mar; 44(3):143-50. PubMed ID: 6220520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An improvement in the technology of manual plasmacytapharesis].
    Zhiburt EB; Popova NN; Baratashvili GG; Sidorkevich SV; Svintsova OV
    Med Tekh; 1998; (3):34-6. PubMed ID: 9720017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor safety and plasma quality in automated plasmapheresis. Comparison of two filter materials.
    Aeschbacher B; Haeberli A; Nydegger UE
    Vox Sang; 1989; 57(2):104-11. PubMed ID: 2528858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of red cell mass in a plasmapheresis machine: effect of rinsing the disposable tubing with normal saline and reinfusion.
    Fischer T; Surikova I; Heesen E; Wilms G; Laitinen T; Taborski U
    Transfus Apher Sci; 2013 Aug; 49(1):80-3. PubMed ID: 23769170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood component collection by apheresis.
    Burgstaler EA
    J Clin Apher; 2006 Jul; 21(2):142-51. PubMed ID: 15880369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum levels of IgG, IgA, IgM, blood proteins and various lysosomal enzymes in donors after repeated plasmapheresis].
    Chocha A; Nenycz A; Szklarska W
    Wiad Lek; 1990 Oct 1-15; 43(19-20):949-52. PubMed ID: 2127490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of posttransplantation plasmapheresis on results of transplantation of a cadaveric kidney].
    Kaabak MM; Goriaĭnov VA; Solov'eva IN; Alekseeva LA; Siniutin AA
    Khirurgiia (Mosk); 2002; (12):30-3. PubMed ID: 12522924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasma pH and anticoagulant solutions used in the plasmapheresis method of blood collection from donors].
    Pták J; Novácková L; Stachelová M; Slabík D; Králová S
    Vnitr Lek; 2000 Feb; 46(2):111-3. PubMed ID: 11048534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Logistics of automated plasma collection.
    McCombie N; Rock G
    J Clin Apher; 1988; 4(2-3):104-7. PubMed ID: 3397371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two red blood cell units collected in SAG-M additive solution with the ALYX component collection system.
    Schooneman F; Huart JJ; Dernis D; Tunez V; Aguettaz D
    Transfus Apher Sci; 2005 Jun; 32(3):305-13. PubMed ID: 15944117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma fractionation in blood transfusion service.
    Haskó F; Salamon M; Bartha K; Dobó P
    Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.